Polymerization of fibrinogen in murine bleomycin-induced lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 271, Issue 4 15-4, 1996, Pages

  Olman, Mitchell A ^a   Simmons, Warren L ^a   Pollman, Daniel J ^a   Loftis, Audrey Y ^a   Bini, Alessandra ^a   Miller, Edward J ^a   Fuller, Gerald M ^a   Rivera, Kimberly E ^a  

^a NONE

Author keywords

extracellular matrix; fibrin deposition; fibrinolysis; pulmonary fibrosis

Indexed keywords

BLEOMYCIN; COLLAGEN; FIBRIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBRIN DEPOSITION; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; QUANTITATIVE ASSAY;

EID: 0029985099     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.271.4.l519     Document Type: Article

References (31)

1. Basset, F., V. J. Ferrans, P. Soler, T. Takemura, Y. Fukuda, and R. G. Crystal. Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 122: 443-461, 1986.
2. Bini, A., J. Fenoglio, J. Sobel, J. Owen, M. Feigl, and K. L. Kaplan. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. Blood 69: 1038-1045, 1987.
3. Bowden, D. H. Unraveling pulmonary fibrosis: the bleomycin model. Lab. Invest. 50: 487-488, 1984.
4. Brown, L. F., N. Lanir, J. McDonagh, K. Tognazzi, A. M. Dvorak, and H. F. Dvorak. Fibroblast migration in fibrin gel matrices. Am. J. Pathol. 142: 273-283, 1993.
5. Burkhardt, A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am. Rev. Respir. Dis. 140: 513-524, 1989.
6. Chapman, H. A., C. L. Allen, and O. L. Stone. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 133: 437-444, 1986.
7. Crouch, E. Pathobiology of pulmonary fibrosis. Am. J. Physiol. 259 (Lung Cell. Mol. Physiol. 3): L159-L184, 1990.
8. Dvorak, H. F., D. R. Senger, A. M. Dvorak, V. S. Harvey, and J. McDonagh. Regulation of extravascular coagulation by microvascular permeability. Science Wash. DC 227: 1059-1961, 1985.
9. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, D. Ginsburg, and R. H. Simon. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 1: 232-237, 1996.
10. Francis, C. W., V. J. Marder, and G. H. Barlow. Plasmic degradation of crosslinked fibrin. J. Clin. Invest. 66: 1033-1043, 1980.
11. Ge, M., G. Tang, T. J. Ryan, and A. B. Malik. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J. Clin. Invest. 90: 2508-2516, 1992.
12. Gray, A. J., J. E. Bishop, J. T. Reeves, and G. J. Laurent. Aα and Bβ chains of fibrinogen stimulate proliferation of human fibroblasts. J. Cell Sci. 104: 409-413, 1993.
13. Gross, T. J., S. M. Cobb, and M. W. Peterson. Asbestos exposure increases paracellular transport of fibrin degradation products across human airway epithelium. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L287-L295, 1994.
14. Hagood, J. S., M. A. Olman, J. G. Zeballos, K. E. Rivera, and G. M. Fuller. Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts. Blood 87: 3749-3757, 1996.
15. Idell, S., J. G. Garcia, K. Gonzalez, J. McLarty, and D. S. Fair. Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease. J. Rheumatol. 16: 592-598, 1989.
16. Idell, S., K. K. James, C. Gillies, D. S. Fair, and R. S. Thrall. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J. Pathol. 135: 387-399, 1989.
17. Idell, S., C. Zwieb, J. Boggaram, D. Holiday, and A. R. Johnson. Mechanisms of fibrin formation and lysis by human lung fibroblasts influence of TGF-β and TNF-α. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L487-L494, 1992.
18. Kuhn, C., III, C., J. Boldt, T. E. King, Jr., E. Crouch, T. Vartio, and J. A. McDonald. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 140: 1693-1703, 1989.
19. Languino, L. R., A. Duperray, K. J. Joganic, M. Fornaro, G. B. Thornton, and D. C. Altieri. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc. Natl. Acad. Sci. USA 92: 1505-1509, 1995.
20. Leavell, K. J., M. W. Peterson, and T. J. Gross. The role of fibrin degradation products in neutrophil recruitment to the lung. Am. J. Respir. Cell Mol. Biol. 14: 53-60, 1996.
21. Manwaring, D., D. Thorning, and P. W. Curreri. Mechanisms of acute pulmonary dysfunction induced by fibrinogen degradation product D. Surgery 84: 45-53, 1978.
22. Mirshahi, M., J. Soria, H. Lu, C. Soria, M. Samama, and J. P. Caen. Defective thrombolysis due to collagen incorporation in fibrin clots. Thromb. Res. 8: 73-80, 1988.
23. Olman, M., N. Mackman, C. Gladson, K. Moser, and D. Loskutoff. Changes in procoagulant and fibrinolytic gene expression during bleomycin induced lung injury in the mouse. J. Clin. Invest. 96: 1621-1630, 1995.
24. Perez, R. L., A. Duncan, R. L. Hunter, and G. W. Staton, Jr. Elevated D dimer in the lungs and blood of patients with sarcoidosis. Chest 103: 1100-1106, 1993.
25. Pizzo, S. V., and J. J. Pasqua. The clearance of human fibrinogen fragments D1, D2, D3 and fibrin fragment D1 dimer in mice. Biochim. Biophys. Acta 718: 177-184, 1982.
26. Seeger, W., G. Stohr, H. R. D. Wolf, and H. Neuhof. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol. 58: 326-338, 1985.
27. Senior, R. M., W. F. Skogen, G. L. Griffin, and G. D. Wilner. Effects of fibrinogen derivatives upon the inflammatory response: studies with human fibrinopeptide B. J. Clin. Invest. 77: 1014-1019, 1986.
28. Simon, D. I., A. M. Ezratty, S. Francis, H. Rennke, and J. Loscalzo. Fibrin(ogen) is internalized and degraded by activated human monocytiod cells via mac-1 (CD11b/CD18): a non-plasmin fibrinolytic pathway. Blood 82: 2414-2422, 1993.
29. Sitrin, R. G., P. G. Brubaker, and J. C. Fantone. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities. Am. Rev. Respir. Dis. 135: 930-938, 1987.
30. Weitz, J. I., E. K. Silverman, B. Thong, and E. J. Campbell. Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. J. Clin. Invest. 89: 766-773, 1992.
31. Zar, J. H. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1984.